Chemomab Therapeutics LTD. (CMMB) SEC Filings — 2024

Filings

• Adi Mor Amends Chemomab Therapeutics Stake — SC 13D/A · Nov 29, 2024
• Chemomab Therapeutics LTD. SC 13G Filing — SC 13G · Nov 21, 2024
• Chemomab Therapeutics Ltd. Holds Special Shareholder Meeting — 6-K · Nov 18, 2024
• Chemomab Therapeutics Q3 2024 Financial Results Filed — 6-K · Nov 14, 2024
• Chemomab Therapeutics Calls Special Shareholder Meeting — 6-K · Oct 11, 2024
• OrbiMed Files 13D/A Amendment for Chemomab Therapeutics — SC 13D/A · Sep 16, 2024
• Chemomab Therapeutics Files Form 6-K — 6-K · Aug 21, 2024
• Chemomab Therapeutics LTD. SC 13G Filing — SC 13G · Aug 20, 2024
• Chemomab Therapeutics Ltd. Files 6-K, Details Former Names — 6-K · Jul 25, 2024
• Chemomab Therapeutics Holds Annual Shareholder Meeting — 6-K · Jun 12, 2024
• Chemomab Therapeutics Q1 2024 Update — 6-K · May 9, 2024
• Chemomab Therapeutics Files 6-K with Press Release — 6-K · May 8, 2024
• Chemomab Therapeutics Files Shareholder Meeting Notice — 6-K · May 3, 2024
• Chemomab Therapeutics Files 20-F for FY2023 — 20-F · Mar 28, 2024
• OrbiMed Files 13D/A Amendment for Chemomab Therapeutics — SC 13D/A · Mar 11, 2024
• Chemomab Therapeutics Reports 2023 Financials & Corporate Update — 6-K · Mar 7, 2024
• Chemomab Completes CM-101 PSC Trial Enrollment, Topline Data Mid-2024 — 6-K · Jan 3, 2024